ORGO - Organogenesis Holdings Inc logo

ORGO

Organogenesis Holdings Inc

Organogenesis Holdings Inc. develops and commercializes regenerative medicine products for advanced wound care and surgical markets, including amnion grafts, bioengineered skin substitutes, and antimicrobial barriers, serving hospitals and clinics in the U.S.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$114today

Score Overview

1 Year
Score
Net Growth-343.66%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-18.91%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.3
Net Growth-195.78%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-2.31%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-41x
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend67%
Revenue Consistency

See the full market ranking โ†’

Organogenesis Holdings Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 338M to $ 563M and net income grew from $ 17M to $ 37M. Revenue increased in 2 of those 5 years; net income in 1.

Organogenesis Holdings Inc currently holds a 5-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.81โ€”
1 Year2025-08-12
$ 4.89-62.99%
5 Years2021-08-12
$ 15.87-88.59%
All Time2017-01-05
$ 9.75-81.44%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 456M-$ 90M$ 46M
2025$ 563M$ 37M$ 93M
2024$ 482M$ 861K$ 135M
2023$ 433M$ 4M$ 104M
2022$ 450M$ 15M$ 102M
2021$ 467M$ 94M$ 113M
2020$ 338M$ 17M$ 84M
2019$ 260M-$ 38M$ 60M
2018$ 193M-$ 64M$ 21M
IPO2017$ 0.00-$ 2M$ 125.89K

Explore beyond ORGO

You're looking at Organogenesis Holdings Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies